NOCERA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 184
EU - Europa 176
AS - Asia 54
AF - Africa 4
OC - Oceania 1
Totale 419
Nazione #
US - Stati Uniti d'America 183
SE - Svezia 109
CN - Cina 25
RU - Federazione Russa 22
SG - Singapore 22
IT - Italia 13
DE - Germania 10
IN - India 6
FI - Finlandia 5
GB - Regno Unito 5
ES - Italia 4
IE - Irlanda 4
NG - Nigeria 4
CZ - Repubblica Ceca 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
IR - Iran 1
PL - Polonia 1
Totale 419
Città #
Ashburn 42
New York 22
Lawrence 20
Princeton 20
Shanghai 20
Boardman 17
Singapore 14
Moscow 8
Rome 7
Pune 6
Helsinki 5
Dublin 4
Bilbao 3
Alvin 2
Cologne 2
Croydon 2
Frankfurt am Main 2
Hanover 2
Holyhead 2
Lagos 2
Mushin 2
Borås 1
Brussels 1
Calgary 1
Crotone 1
Fort Lauderdale 1
Kish 1
Los Angeles 1
Majadahonda 1
Melbourne 1
Middlesbrough 1
Padova 1
San Antonio 1
San Mateo 1
The Bronx 1
Tucson 1
Washington 1
Totale 220
Nome #
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 32
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 28
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 26
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 23
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 21
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 20
Improving the stratification of intermediate risk prostate cancer 20
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 19
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 19
Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma 18
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 16
External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study 15
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients 15
The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer 14
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients 14
Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder 14
The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients 13
Differences between rural and urban prostate cancer patients 12
Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol 2020;78:360–368 12
Comparison Between Urothelial and Non-Urothelial Urethral Cancer 12
Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation 12
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy 12
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 10
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 10
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients 6
Totale 446
Categoria #
all - tutte 5.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 9 0 0 6 0 0 0
2021/202222 0 2 1 12 0 0 1 0 2 1 0 3
2022/2023177 50 39 18 8 7 23 5 16 6 1 3 1
2023/2024183 3 12 14 20 17 38 1 39 0 6 8 25
2024/202549 49 0 0 0 0 0 0 0 0 0 0 0
Totale 446